Given that PAK inhibition sensitizes mutant RAS- and BRAF-driven cell lines to the inhibition of the MAPK cascade [19,20,21], we hypothesized that PAK inhibition would also be able to sensitize GNAQ and GNA11 mutant uveal melanoma cells to MEK inhibitors. The gene discussed is BRAF; the disease is uveal melanoma.